---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-036866"
form_type: "8-K"
ticker: "RNAZ"
cik: "0001829635"
company_name: "Transcode Therapeutics, Inc."
filed_at: "2025-04-21T23:59:59+00:00"
generated_at: "2026-05-23T10:33:09.954933+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# TransCode adjourns special meeting due to lack of quorum; reconvenes May 2 for reverse split vote

## Summary
- Only 12.73% of outstanding shares voted at April 21 special meeting; quorum required one-third.
- Adjourned meeting reconvenes May 2, 2025 at 9:30 a.m. ET virtually at www.virtualshareholdermeeting.com/RNAZ2025SM2.
- Proposal 1: reverse stock split at ratio from 1:10 to 1:40, board discretion.
- Proposal 2: adjournment if needed; record date still April 2, 2025.
- New vote deadline May 1, 2025 at 11:59 p.m. ET; company continues solicitation.

## SEC filing metadata
- accession: 0001104659-25-036866
- form_type: 8-K
- ticker: RNAZ
- cik: 0001829635
- company_name: Transcode Therapeutics, Inc.
- filed_at: 2025-04-21T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.07, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1829635/000110465925036866/0001104659-25-036866-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1829635/000110465925036866/tm2512771d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-036866
- JSON: https://secwatch.observer/filing/0001104659-25-036866.json
- Plain text: https://secwatch.observer/filing/0001104659-25-036866.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.